Systematic Review of Studies Investigating Hospital Readmissions in Pediatric Oncology
Pediatric Blood & Cancer · 2025-02 · 72 (2)
DOI: 10.1002/pbc.31459 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 25.11.2024. Verfasst von Hadeel Hassan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Patient Readmission, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Canada Research Chair in Pediatric Oncology Supportive Care, Garron Family Cancer Centre (GFCC) at the Hospital for Sick Children.
Abstract (Originalsprache)
Purpose
This systematic review aimed to identify and synthesize evidence on hospital readmissions among pediatric oncology patients, focusing on the indications, risk factors, and proposed strategies to prevent readmissions.
Method
The review followed PRISMA 2020 guidelines. Databases including Embase, Medline, Scopus, Mendeley, and Google Scholar were searched. Studies examining hospital readmission as a main outcome in pediatric cancer patients, including those undergoing surgical oncology procedures or receiving hematopoietic cell transplantation, were included. Quality assessment was undertaken using the Newcastle–Ottawa Scale and PROBAST tool.
Results
A total of 18 studies met the inclusion criteria. The studies spanned from 2008 to 2023, with an increase in publications from 2020 onward (61%). Fever and infection were the most common readmission indications. Statistically significant risk factors reported included younger age, specific cancer types (e.g., acute lymphoblastic leukemia), and socioeconomic factors. Prevention strategies proposed included early follow‐up, tailored anticipatory guidance, discharge education, and specialized care at pediatric oncology centers.
Conclusions
This systematic review highlights the multifaceted nature of hospital readmissions in pediatric oncology patients and the need for standardized definitions, additional studies, and comprehensive interventions. Future research should focus on high‐quality prospective studies, integration of predictive analytics, and addressing socioeconomic disparities to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
- Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada.
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Amy Duoli Lu, Adam Paul Yan
Förderung
- Canada Research Chair in Pediatric Oncology Supportive Care
- Garron Family Cancer Centre (GFCC) at the Hospital for Sick Children
Zitieren
APA
Hassan, H., Chen, Y., Lu, A. D., Arciniegas, S. E., Yan, A. P., Guo, L. L., & Sung, L. (2025). Systematic Review of Studies Investigating Hospital Readmissions in Pediatric Oncology. Pediatric Blood & Cancer, 72(2). https://doi.org/10.1002/pbc.31459
Vancouver
Hassan H, Chen Y, Lu AD, Arciniegas SE, Yan AP, Guo LL, et al. Systematic Review of Studies Investigating Hospital Readmissions in Pediatric Oncology. Pediatric Blood & Cancer. 2025;72(2). doi:10.1002/pbc.31459
BibTeX
@article{Hassan2025,
author = {Hassan, Hadeel and Chen, Yujie and Lu, Amy Duoli and Arciniegas, Santiago Eduardo and Yan, Adam Paul and Guo, Lin Lawrence and Sung, Lillian},
title = {Systematic Review of Studies Investigating Hospital Readmissions in Pediatric Oncology},
journal = {Pediatric Blood & Cancer},
year = {2025},
volume = {72},
number = {2},
doi = {10.1002/pbc.31459}
}
EUVIMED